Danaher

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Danaher and other ETFs, options, and stocks.

About DHR

Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial, and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.

CEO

Rainer M. Blair

CEORainer M. Blair

Employees

80,000

Employees80,000

Headquarters

Washington, District of Columbia

HeadquartersWashington, District of Columbia

Founded

1984

Founded1984

Employees

80,000

Employees80,000

DHR Key Statistics

Market cap

188.06B

Market cap188.06B

Price-Earnings ratio

30.42

Price-Earnings ratio30.42

Dividend yield

0.37

Dividend yield0.37

Average volume

2.32M

Average volume2.32M

High today

$265.60

High today$265.60

Low today

$257.13

Low today$257.13

Open price

$262.00

Open price$262.00

Volume

2.67M

Volume2.67M

52 Week high

$331.69

52 Week high$331.69

52 Week low

$233.71

52 Week low$233.71

DHR News

Simply Wall St 2d

Is Danaher Corporation's Stock's Recent Performance A Reflection Of Its Financial Health? - Simply Wall St

Danaher's (NYSE:DHR) stock is up by 5.0% over the past three months. Given its impressive performance, we decided to study the company's key financial indicator...

Simply Wall St 3d

Danaher Corporation insiders sold US$389m worth of stock, possibly signalling a downtrend

Many Danaher Corporation (NYSE:DHR) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When evaluating ins...

Simply Wall St 7d

When Should You Buy Danaher Corporation?

Today we're going to take a look at the well-established Danaher Corporation (NYSE:DHR). The company's stock saw a double-digit share price rise of over 10% in...

Analyst ratings

83%

of 24 ratings

Buy

83.3%

Hold

12.5%

Sell

4.2%

DHR Earnings

$0.00

$0.92

$1.84

$2.76

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Available Oct 20, Pre-Market

ActualAvailable Oct 20, Pre-Market